SARS-CoV-2 vaccination and risk of severe COVID-19 outcomes in patients with autoimmune hepatitis

Cumali Efe, Koray Taşçılar, Alessio Gerussi, Francesca Bolis, Craig Lammert, Berat Ebik, Albert Friedrich Stättermayer, Mustafa Cengiz, Dilara Turan Gökçe, Laura Cristoferi, Mirta Peralta, Hatef Massoumi, Pedro Montes, Eira Cerda, Cristina Rigamonti, Suna Yapalı, Gupse Adalı, Ali Rıza Çalışkan, Yasemin Balaban, Fatih Eren, Tuğçe Eşkazan, Sezgin Barutçu, Ellina Lytvyak, Godolfino Miranda Zazueta, Meral Akdoğan, Alexandra Heurgué–Berlot, Eléonora De Martin, Ahmet Yavuz, Murat Bıyık, Graciela Castro Narro, Serkan Duman, Nelia Hernández, Nikolaos Gatselis, Jonathan Aguirre, Ramazan Idılman, Marcelo Silva, Manuel Mendizábal, Kadri Atay, Fatih Güzelbulut, Renumathy Dhanasekaran, Aldo J. Montaño‐Loza, George Ν. Dalekos, Ezequiel Ridruejo, Pietro Invernizzi, Staffan Wåhlin